The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Neurofibromatosis type 1
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Need for a New Medical Model: A Challenge for Biomedicine
Engel, G. L. (1977) · Science · doi:10.1126/science.847460 · Cited by 12,887
Neurofibromatosis: Conference Statement
(1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520290115023 · Cited by 1,547
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,475
Trofatter, J. (1993) · Cell · doi:10.1016/0092-8674(93)90406-g · Cited by 1,403
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
Evans, D. G. R., Baser, M. E., McGaughran, J., Sharif, S., Howard, E., & Moran, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.5.311 · Cited by 1,282
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver, M., Carey, J. C., Copeland, N. G., Jenkins, N. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90252-a · Cited by 1,082
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Ferner, R. E., Huson, S. M., Thomas, N., Moss, C., Willshaw, H., Evans, D. G., Upadhyaya, M., Towers, R., Gleeson, M., Steiger, C., et al. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.045906 · Cited by 1,053
Self-citationGastrointestinal stromal tumour
Rubin, B. P., Heinrich, M. C., & Corless, C. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60780-6 · Cited by 1,036
Frustaci, S., Gherlinzoni, F., De Paoli, A., Bonetti, M., Azzarelli, A., Comandone, A., Olmi, P., Buonadonna, A., Pignatti, G., Barbieri, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1238 · Cited by 712
Gastrointestinal stromal tumour
Joensuu, H., Hohenberger, P., & Corless, C. L. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60106-3 · Cited by 703
Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
Dombi, E., Baldwin, A., Marcus, L. J., Fisher, M. J., Weiss, B., Kim, A., Whitcomb, P., Martin, S., Aschbacher-Smith, L. E., Rizvi, T. A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1605943 · Cited by 682
Self-citationAberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients
Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S., & Downward, J. (1992) · Nature · doi:10.1038/356713a0 · Cited by 668
Self-citationThe nature and frequency of cognitive deficits in children with neurofibromatosis type 1
Hyman, S. L., Shores, A., & North, K. N. (2005) · Neurology · doi:10.1212/01.wnl.0000179303.72345.ce · Cited by 637
Packer, R. J., Ater, J., Allen, J., Phillips, P., Geyer, R., Nicholson, H. S., Jakacki, R., Kurczynski, E., Needle, M., Finlay, J., et al. (1997) · Journal of Neurosurgery · doi:10.3171/jns.1997.86.5.0747 · Cited by 636
Neurofibromatosis type 1: a multidisciplinary approach to care
Hirbe, A. C., & Gutmann, D. H. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70063-8 · Cited by 626
Self-citationLee, W., Teckie, S., Wiesner, T., Ran, L., Prieto Granada, C. N., Lin, M., Zhu, S., Cao, Z., Liang, Y., Sboner, A., et al. (2014) · Nature Genetics · doi:10.1038/ng.3095 · Cited by 619
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.
Ferner, R. E., & Gutmann, D. H. (2002) · PubMed · Cited by 603
Self-citationThe NF1 tumor suppressor critically regulates TSC2 and mTOR
Johannessen, C. M., Reczek, E. E., James, M. F., Brems, H., Legius, E., & Cichowski, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503224102 · Cited by 601
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1
Costa, R. M., Federov, N. B., Kogan, J. H., Murphy, G. G., Stern, J., Ohno, M., Kucherlapati, R., Jacks, T., & Silva, A. J. (2002) · Nature · doi:10.1038/nature711 · Cited by 585
Use of the National Institutes of Health Criteria for Diagnosis of Neurofibromatosis 1 in Children
DeBella, K., Szudek, J., & Friedman, J. M. (2000) · Pediatrics · doi:10.1542/peds.105.3.608 · Cited by 581
Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations
Listernick, R., Ferner, R. E., Liu, G. T., & Gutmann, D. H. (2007) · Annals of Neurology · doi:10.1002/ana.21107 · Cited by 576
Self-citationListernick, R., Charrow, J., Greenwald, M., & Mets, M. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70122-9 · Cited by 548
Self-citationHuson, S. M., Compston, D. A., Clark, P., & Harper, P. S. (1989) · Journal of Medical Genetics · doi:10.1136/jmg.26.11.704 · Cited by 540
Mortality in Neurofibromatosis 1: An Analysis Using U.S. Death Certificates
Rasmussen, S. A., Yang, Q., & Friedman, J. M. (2001) · The American Journal of Human Genetics · doi:10.1086/320121 · Cited by 530
Messiaen, L. M., Callens, T., Mortier, G., Beysen, D., Vandenbroucke, I., Van Roy, N., Speleman, F., & Paepe, A. D. (2000) · Human Mutation · doi:10.1002/1098-1004(200006)15:6<541::aid-humu6>3.0.co;2-n · Cited by 521
Listernick, R., Louis, D. N., Packer, R. J., & Gutmann, D. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410204 · Cited by 478
Self-citationMouse Models of Tumor Development in Neurofibromatosis Type 1
Cichowski, K., Shih, T. S., Schmitt, E., Santiago, S., Reilly, K., McLaughlin, M. E., Bronson, R. T., & Jacks, T. (1999) · Science · doi:10.1126/science.286.5447.2172 · Cited by 467
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
De Raedt, T., Beert, E., Pasmant, E., Luscan, A., Brems, H., Ortonne, N., Helin, K., Hornick, J. L., Mautner, V., Kehrer-Sawatzki, H., et al. (2014) · Nature · doi:10.1038/nature13561 · Cited by 461
Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning
Cui, Y., Costa, R. M., Murphy, G. G., Elgersma, Y., Zhu, Y., Gutmann, D. H., Parada, L. F., Mody, I., & Silva, A. J. (2008) · Cell · doi:10.1016/j.cell.2008.09.060 · Cited by 440
Self-citationDistinctive Cancer Associations in Patients With Neurofibromatosis Type 1
Uusitalo, E., Rantanen, M., Kallionpää, R. A., Pöyhönen, M., Leppävirta, J., Ylä-Outinen, H., Riccardi, V. M., Pukkala, E., Pitkäniemi, J., Peltonen, S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.3576 · Cited by 418
Li, W., Cui, Y., Kushner, S. A., Brown, R. A. M., Jentsch, J. D., Frankland, P. W., Cannon, T. D., & Silva, A. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.09.043 · Cited by 402
Germline Mutation of INI1/SMARCB1 in Familial Schwannomatosis
Hulsebos, T. J. M., Plomp, A. S., Wolterman, R. A., Robanus-Maandag, E. C., Baas, F., & Wesseling, P. (2007) · The American Journal of Human Genetics · doi:10.1086/513207 · Cited by 398
The clinical and diagnostic implications mosaicism in the neurofibromatoses
Ruggieri, M., & Huson, S. M. (2001) · Neurology · doi:10.1212/wnl.56.11.1433 · Cited by 387
Sharif, S., Ferner, R., Birch, J. M., Gillespie, J. E., Gattamaneni, H. R., Baser, M. E., & Evans, D. G. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8349 · Cited by 377
Self-citationCarli, M., Ferrari, A., Mattke, A., Zanetti, I., Casanova, M., Bisogno, G., Cecchetto, G., Alaggio, R., De Sio, L., Koscielniak, E., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4886 · Cited by 371
Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow
Yang, F.-C., Ingram, D. A., Chen, S., Zhu, Y., Yuan, J., Li, X., Yang, X., Knowles, S., Horn, W., Li, Y., et al. (2008) · Cell · doi:10.1016/j.cell.2008.08.041 · Cited by 364
Upadhyaya, M., Huson, S. M., Davies, M., Thomas, N., Chuzhanova, N., Giovannini, S., Evans, D. G., Howard, E., Kerr, B., Griffiths, S., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/510781 · Cited by 362
VON RECKLINGHAUSEN′S DISEASE AND PHEOCHROMOCYTOMAS
Walther, M. M., Herring, J., Enquist, E., Keiser, H. R., & Linehan, W. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68171-2 · Cited by 361
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
Jessen, W. J., Miller, S. J., Jousma, E., Wu, J., Rizvi, T. A., Brundage, M. E., Eaves, D., Widemann, B., Kim, M.-O., Dombi, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci60578 · Cited by 334
Association between benign and malignant peripheral nerve sheath tumors in NF1
Tucker, T., Wolkenstein, P., Revuz, J., Zeller, J., & Friedman, J. M. (2005) · Neurology · doi:10.1212/01.wnl.0000168830.79997.13 · Cited by 311
Elevated Risk for MPNST in NF1 Microdeletion Patients
De Raedt, T., Brems, H., Wolkenstein, P., Vidaud, D., Pilotti, S., Perrone, F., Mautner, V., Frahm, S., Sciot, R., & Legius, E. (2003) · The American Journal of Human Genetics · doi:10.1086/374821 · Cited by 310
Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland
Uusitalo, E., Leppävirta, J., Koffert, A., Suominen, S., Vahtera, J., Vahlberg, T., Pöyhönen, M., Peltonen, J., & Peltonen, S. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.465 · Cited by 308
Dasgupta, B., Yi, Y., Chen, D. Y., Weber, J. D., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4058 · Cited by 308
Self-citationOptic gliomas in children with neurofibromatosis type 1
Listernick, R., Charrow, J., Greenwald, M. J., & Esterly, N. B. (1989) · The Journal of Pediatrics · doi:10.1016/s0022-3476(89)80137-4 · Cited by 307
Self-citationAndersson, J., Sihto, H., Meis-Kindblom, J. M., Joensuu, H., Nupponen, N., & Kindblom, L.-G. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000159775.77912.15 · Cited by 303
Guillamo, J.-S., Creange, A., Kalifa, C., Grill, J., Rodriguez, D., Doz, F., Barbarot, S., Zerah, M., Sanson, M., Bastuji-Garin, S., et al. (2003) · Brain · doi:10.1093/brain/awg016 · Cited by 295
Identification of the neurofibromatosis type 1 gene product.
Gutmann, D. H., Wood, D. L., & Collins, F. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9658 · Cited by 278
Self-citationOptic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
Bajenaru, M. L., Hernandez, M. R., Perry, A., Zhu, Y., Parada, L. F., Garbow, J. R., & Gutmann, D. H. (2003) · PubMed · Cited by 275
Self-citationNeurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.
DiPaolo, D. P., Zimmerman, R. A., Rorke, L. B., Zackai, E. H., Bilaniuk, L. T., & Yachnis, A. T. (1995) · Radiology · doi:10.1148/radiology.195.3.7754001 · Cited by 274
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
Mautner, V.-F., Asuagbor, F. A., Dombi, E., Fünsterer, C., Kluwe, L., Wenzel, R., Widemann, B. C., & Friedman, J. M. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-011 · Cited by 260
Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors
Beert, E., Brems, H., Daniëls, B., De Wever, I., Van Calenbergh, F., Schoenaers, J., Debiec‐Rychter, M., Gevaert, O., De Raedt, T., Van Den Bruel, A., et al. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20921 · Cited by 255
Spontaneous mutation and parental age in humans.
RISCH, N. J., Reich, E. W., Wishnick, M., & McCarthy, J. G. (1987) · Europe PMC (PubMed Central) · Cited by 248
NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype
Pasmant, E., Sabbagh, A., Spurlock, G., Laurendeau, I., Grillo, E., Hamel, M.-J., Martin, L., Barbarot, S., Leheup, B., Rodriguez, D., et al. (2010) · Human Mutation · doi:10.1002/humu.21271 · Cited by 244
Hyman, S. L., Arthur Shores, E., & North, K. N. (2006) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162206002131 · Cited by 244
Sharif, S., Moran, A., Huson, S. M., Iddenden, R., Shenton, A., Howard, E., & Evans, D. G. R. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.049346 · Cited by 242
A prospective study of neurofibromatosis type 1 cancer incidence in the UK
Walker, L., Thompson, D., Easton, D., Ponder, B., Ponder, M., Frayling, I., & Baralle, D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603227 · Cited by 240
Wu, J., Williams, J. P., Rizvi, T. A., Kordich, J. J., Witte, D., Meijer, D., Stemmer-Rachamimov, A. O., Cancelas, J. A., & Ratner, N. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.027 · Cited by 236
Robertson, K. A., Nalepa, G., Yang, F.-C., Bowers, D. C., Ho, C. Y., Hutchins, G. D., Croop, J. M., Vik, T. A., Denne, S. C., Parada, L. F., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70414-x · Cited by 234
Elefteriou, F., Benson, M. D., Sowa, H., Starbuck, M., Liu, X., Ron, D., Parada, L. F., & Karsenty, G. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.010 · Cited by 233
Halloran, J., Hussong, S. A., Burbank, R., Podlutskaya, N., Fischer, K. E., Sloane, L. B., Austad, S. N., Strong, R., Richardson, A., Hart, M. J., et al. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.06.054 · Cited by 221
Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/– mast cells
Feng-Chun, Y., Ingram, D. A., Chen, S., Hingtgen, C. M., Ratner, N., Monk, K. R., Clegg, T., White, H., Mead, L., Wenning, M. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19195 · Cited by 221
Seminog, O. O., & Goldacre, M. J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.535 · Cited by 218
Identification and characterization of the neurofibromatosis type 1 protein product.
DeClue, J. E., Cohen, B. D., & Lowy, D. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9914 · Cited by 215
Hegedus, B., Dasgupta, B., Shin, J. E., Emnett, R. J., Hart-Mahon, E. K., Elghazi, L., Bernal-Mizrachi, E., & Gutmann, D. H. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.008 · Cited by 212
Self-citationQuality-of-Life Impairment in Neurofibromatosis Type 1: A Cross-sectional Study of 128 Cases
Wolkenstein, P., Zeller, J., Revuz, J., Ecosse, E., & Leplège, A. (2001) · Archives of Dermatology · doi:10.1001/archderm.137.11.1421 · Cited by 208
Evans, D. G. R., O'Hara, C., Wilding, A., Ingham, S. L., Howard, E., Dawson, J., Moran, A., Scott-Kitching, V., Holt, F., & Huson, S. M. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.113 · Cited by 197
Daginakatte, G. C., & Gutmann, D. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm059 · Cited by 193
Self-citationKrab, L. C. (2008) · JAMA · doi:10.1001/jama.300.3.287 · Cited by 193
Neurofibromatosis Type 1 and Autism Spectrum Disorder
Garg, S., Green, J., Leadbitter, K., Emsley, R., Lehtonen, A., Evans, D. G., & Huson, S. M. (2013) · Pediatrics · doi:10.1542/peds.2013-1868 · Cited by 192
Rojnueangnit, K., Xie, J., Gomes, A., Sharp, A., Callens, T., Chen, Y., Liu, Y., Cochran, M., Abbott, M., Atkin, J., et al. (2015) · Human Mutation · doi:10.1002/humu.22832 · Cited by 188
Self-citationCell of Origin and Microenvironment Contribution for NF1-Associated Dermal Neurofibromas
Le, L. Q., Shipman, T., Burns, D. K., & Parada, L. F. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.017 · Cited by 185
Health Supervision for Children With Neurofibromatosis
Hersh, J. H., & Committee on Genetics (2008) · Pediatrics · doi:10.1542/peds.2007-3364 · Cited by 184
DeClue, J. E., Heffelfinger, S., Benvenuto, G., Ling, B., Li, S., Rui, W., Vass, W. C., Viskochil, D., & Ratner, N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7610 · Cited by 172
Zöller, M., Rembeck, B., Akesson, H. O., & Angervall, L. (1995) · Acta Dermato-Venereologica · doi:10.2340/0001555575136140 · Cited by 170
The Loss of Nf1 Transiently Promotes Self-Renewal but Not Tumorigenesis by Neural Crest Stem Cells
Joseph, N. M., Mosher, J. T., Buchstaller, J., Snider, P., McKeever, P. E., Lim, M., Conway, S. J., Parada, L. F., Zhu, Y., & Morrison, S. J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.003 · Cited by 167
Double Inactivation of NF1 in Tibial Pseudarthrosis
Stevenson, D. A., Zhou, H., Ashrafi, S., Messiaen, L. M., Carey, J. C., D’Astous, J. L., Santora, S. D., & Viskochil, D. H. (2006) · The American Journal of Human Genetics · doi:10.1086/504441 · Cited by 166
Precocious puberty in children with neurofibromatosis type 1
Habiby, R., Silverman, B., Listernick, R., & Charrow, J. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70449-3 · Cited by 160
Self-citationNf1+/− mast cells induce neurofibroma like phenotypes through secreted TGF-β signaling
Yang, F.-C., Chen, S., Clegg, T., Li, X., Morgan, T., Estwick, S. A., Yuan, J., Khalaf, W., Burgin, S., Travers, J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl165 · Cited by 160
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1)
Gutmann, D. H., Rasmussen, S. A., Wolkenstein, P., MacCollin, M. M., Guha, A., Inskip, P. D., North, K. N., Poyhonen, M., Birch, P. H., & Friedman, J. M. (2002) · Neurology · doi:10.1212/wnl.59.5.759 · Cited by 158
Self-citationWarbey, V. S., Ferner, R. E., Dunn, J. T., Calonje, E., & O’Doherty, M. J. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-1038-0 · Cited by 158
Self-citationTumors of the Peripheral Nervous System
Antonescu, C. R., Scheithauer, B. W., & Woodruff, J. M. (2013) · doi:10.55418/9781933477305 · Cited by 157
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1
Diggs‐Andrews, K. A., Brown, J. A., Gianino, S. M., Rubin, J. B., Wozniak, D. F., & Gutmann, D. H. (2013) · Annals of Neurology · doi:10.1002/ana.24093 · Cited by 152
Self-citationWeiss, B., Widemann, B. C., Wolters, P. L., Dombi, E., Vinks, A. A. T. M. M., Cantor, A. B., Perentesis, J. P., Schorry, E. K., Ullrich, N. J., Gutmann, D. H., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou235 · Cited by 151
Self-citationImpact of neurofibromatosis 1 on Quality of Life: A cross‐sectional study of 176 American cases
Page, P. Z., Page, G. P., Écosse, E., Korf, B. R., Leplège, A., & Wolkenstein, P. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31422 · Cited by 151
Self-citationOptic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome
King, A. A., Listernick, R., Charrow, J., Piersall, L. D., & Gutmann, D. H. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.20211 · Cited by 151
Self-citationMo, W., Chen, J., Patel, A. J., Zhang, L., Chau, V., Li, Y., Cho, W., Lim, K., Xu, J., Lazar, A. J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.053 · Cited by 150
Brown, J. A., Emnett, R. J., White, C. R., Yuede, C. M., Conyers, S. B., O’Malley, K. L., Wozniak, D. F., & Gutmann, D. H. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq382 · Cited by 147
Self-citationPrada, C. E., Jousma, E., Rizvi, T. A., Wu, J., Dunn, R. S., Mayes, D. A., Cancelas, J. A., Dombi, E., Kim, M., West, B. L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1056-7 · Cited by 146
Simmons, G. W., Pong, W. W., Emnett, R. J., White, C. R., Gianino, S. M., Rodriguez, F. J., & Gutmann, D. H. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182032d37 · Cited by 139
Self-citationGraf, A., Landolt, M. A., Mori, A. C., & Boltshauser, E. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.04.025 · Cited by 139
Yang, F., Shi, C., Robling, A. G., Yu, X., Nebesio, T. D., Yan, J., Morgan, T., Li, X., Yuan, J., Hock, J. M., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29092 · Cited by 138
Renovascular disease and hypertension in children with neurofibromatosis
Fossali, E. F., Signorini, E., Intermite, R., Casalini, E., Lovaria, A., Maninetti, M. M., & Rossi, L. N. (2000) · Pediatric Nephrology · doi:10.1007/s004679900260 · Cited by 136
Morris, S. M., Acosta, M. T., Garg, S., Green, J., Huson, S., Legius, E., North, K. N., Payne, J. M., Plasschaert, E., Frazier, T. W., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2600 · Cited by 136
Self-citationPreclinical Cancer Therapy in a Mouse Model of Neurofibromatosis-1 Optic Glioma
Hegedűs, B., Banerjee, D., Yeh, T., Rothermich, S. Y., Perry, A., Rubin, J. B., Garbow, J. R., & Gutmann, D. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5916 · Cited by 135
Self-citationvan der Vaart, T., Plasschaert, E., Rietman, A. B., Renard, M., Oostenbrink, R., Vogels, A., de Wit, M. Y., Descheemaeker, M., Vergouwe, Y., Catsman‐Berrevoets, C. E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70227-8 · Cited by 135
Duong, T. A., Sbidian, É., Valeyrie‐Allanore, L., Viallette, C., Ferkal, S., Hadj-Rabia, S., Glorion, C., Lyonnet, S., Zérah, M., Kemlin, I., et al. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-18 · Cited by 134
Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase
Molosh, A. I., Johnson, P. L., Spence, J. P., Arendt, D. H., Federici, L. M., Bernabe, C., Janasik, S. P., Segu, Z. M., Khanna, R., Goswami, C. P., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3822 · Cited by 133
Gutmann, D. H., McLellan, M. D., Hussain, I., Wallis, J. W., Fulton, L., Fulton, R. S., Magrini, V. J., Demeter, R., Wylie, T., Kandoth, C., et al. (2012) · Genome Research · doi:10.1101/gr.142604.112 · Cited by 130
Self-citationDasgupta, B., Yi, Y., Hegedűs, B., Weber, J. D., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1842 · Cited by 128
Self-citationLate-onset optic pathway tumors in children with neurofibromatosis 1
Listernick, R., Ferner, R. E., Piersall, L. D., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144341.16830.01 · Cited by 127
Self-citationSomatic Mutation Analysis in NF1 Café au lait Spots Reveals Two NF1 Hits in the Melanocytes
Schepper, S. D., Maertens, O., Callens, T., Naeyaert, J. M., Lambert, J., & Messiaen, L. M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701095 · Cited by 125
Widemann, B. C., Dombi, E., Gillespie, A., Wolters, P. L., Belasco, J. B., Goldman, S., Korf, B. R., Solomon, J. M., Martin, S. C., Salzer, W. L., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou004 · Cited by 124
Self-citationLee, D. Y., Yeh, T.-H., Emnett, R. J., White, C. R., & Gutmann, D. H. (2010) · Genes & Development · doi:10.1101/gad.1957110 · Cited by 119
Self-citationReduced microglial CX3CR1 expression delays neurofibromatosis‐1 glioma formation
Pong, W. W., Higer, S. B., Gianino, S. M., Emnett, R. J., & Gutmann, D. H. (2012) · Annals of Neurology · doi:10.1002/ana.23813 · Cited by 116
Self-citationPTEN dosage is essential for neurofibroma development and malignant transformation
Gregorian, C., Nakashima, J. K., Dry, S., Nghiemphu, P. L., Smith, K. B., Ao, Y., Dang, J. H. T., Lawson, G. W., Mellinghoff, I. K., Mischel, P. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910398106 · Cited by 115
Brown, J. A., Gianino, S. M., & Gutmann, D. H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3994-09.2010 · Cited by 114
Self-citationWang, W., Nyman, J. S., Ono, K., Stevenson, D. A., Yang, X., & Elefteriou, F. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr310 · Cited by 114
Daginakatte, G., Gianino, S. M., Zhao, N. W., Parsadanian, A. S., & Gutmann, D. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2506 · Cited by 114
Self-citationWolters, P. L., Burns, K. M., Martin, S. C., Baldwin, A. M., Dombi, E., Toledo‐Tamula, M. A., Dudley, W. N., Gillespie, A., & Widemann, B. C. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37123 · Cited by 112
Self-citationCells of Origin in the Embryonic Nerve Roots for NF1-Associated Plexiform Neurofibroma
Chen, Z., Liu, C., Patel, A. J., Liao, C.-P., Wang, Y., & Le, L. Q. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.009 · Cited by 112
Innate Neural Stem Cell Heterogeneity Determines the Patterning of Glioma Formation in Children
Lee, D. Y., Gianino, S. M., & Gutmann, D. H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.036 · Cited by 110
Self-citationSusceptible Stages in Schwann Cells for NF1-Associated Plexiform Neurofibroma Development
Le, L. Q., Liu, C., Shipman, T. E., Chen, Z., Suter, U., & Parada, L. F. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4577 · Cited by 110
Cambiaghi, S., Restano, L., & Caputo, R. (2004) · Pediatric Dermatology · doi:10.1111/j.0736-8046.2004.21201.x · Cited by 106
Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1
Payne, J. M., Barton, B., Ullrich, N. J., Cantor, A. B., Hearps, S. J. C., Cutter, G., Rosser, T. L., Walsh, K. S., Gioia, G. A., Wolters, P. L., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003435 · Cited by 106
Self-citationSolga, A. C., Pong, W. W., Keun-young Kim, A., Cimino, P. J., Toonen, J. A., Walker, J., Wylie, T., Magrini, V. J., Griffith, M., Griffith, O. L., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2015.10.002 · Cited by 104
Self-citationEpilepsy in individuals with neurofibromatosis type 1
Ostendorf, A. P., Gutmann, D. H., & Weisenberg, J. L. Z. (2013) · Epilepsia · doi:10.1111/epi.12348 · Cited by 102
Self-citationGlioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes
Dasgupta, B., Li, W., Perry, A., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.236.65.1 · Cited by 101
Self-citationBanerjee, S., Crouse, N. R., Emnett, R. J., Gianino, S. M., & Gutmann, D. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019012108 · Cited by 100
Self-citationAdvances in the treatment of neurofibromatosis-associated tumours
Lin, A. L., & Gutmann, D. H. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.144 · Cited by 99
Self-citationVranceanu, A., Merker, V. L., Park, E. R., & Plotkin, S. R. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1195-2 · Cited by 98
Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth
Kaul, A., Toonen, J. A., Cimino, P. J., Gianino, S. M., & Gutmann, D. H. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou329 · Cited by 98
Self-citationThe Development of Cutaneous Neurofibromas
Jouhilahti, E., Peltonen, S. A., Callens, T., Jokinen, E., Heape, A. M., Messiaen, L. M., & Peltonen, J. T. K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.041 · Cited by 94
Krab, L. C., Oostenbrink, R., de Goede-Bolder, A., Aarsen, F. K., Elgersma, Y., & Moll, H. A. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.08.045 · Cited by 93
HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1
Omrani, A., van der Vaart, T., Mientjes, E., van Woerden, G. M., Hojjati, M. R., Li, K. W., Gutmann, D. H., Levelt, C. N., Smit, A. B., Silva, A. J., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.48 · Cited by 93
Self-citationEvans, D. G., Bowers, N. L., Burkitt‐Wright, E., Miles, E. K., Garg, S., Scott-Kitching, V., Penman-Splitt, M., Dobbie, A., Howard, E., Ealing, J., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.04.005 · Cited by 92
Neuronal NF1/RAS regulation of cyclic AMP requires atypical PKC activation
Anastasaki, C., & Gutmann, D. H. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu389 · Cited by 91
Self-citationWeiss, B., Widemann, B. C., Wolters, P. L., Dombi, E., Vinks, A. A. T. M. M., Cantor, A. B., Korf, B. R., Perentesis, J. P., Gutmann, D. H., Schorry, E. K., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24873 · Cited by 91
Self-citationDiagnosis and Management of Pheochromocytoma: A Practical Guide to Clinicians
Pappachan, J. M., Raskauskiene, D., Sriraman, R., Edavalath, M., & Hanna, F. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0442-z · Cited by 85
BRAINSTEM LESIONS IN NEUROFIBROMATOSIS TYPE 1
Ullrich, N. J., Raja, A. I., Irons, M., Kieran, M. W., & Goumnerova, L. (2007) · Neurosurgery · doi:10.1227/01.neu.0000298904.63635.2d · Cited by 85
Optimizing biologically targeted clinical trials for neurofibromatosis
Gutmann, D. H., Blakeley, J. O., Korf, B. R., & Packer, R. J. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.772979 · Cited by 85
Self-citationNeurofibroma and Cellular Neurofibroma With Atypia
Lin, B. T.-Y., Weiss, L. M., & Medeiros, L. J. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199712000-00006 · Cited by 85
Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)
Ferner, R. E., Hughes, R. A. C., Hall, S. M., Upadhyaya, M., & Johnson, M. R. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.021683 · Cited by 82
Self-citationGranström, S., Langenbruch, A. K., Augustin, M., & Mautner, V. (2012) · Dermatology · doi:10.1159/000337548 · Cited by 82
Martin, S. C., Wolters, P. L., Baldwin, A., Gillespie, A., Dombi, E., Walker, K., & Widemann, B. C. (2012) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsr124 · Cited by 81
Self-citationDopamine deficiency underlies learning deficits in neurofibromatosis‐1 mice
Diggs‐Andrews, K. A., Tokuda, K., Izumi, Y., Zorumski, C. F., Wozniak, D. F., & Gutmann, D. H. (2012) · Annals of Neurology · doi:10.1002/ana.23793 · Cited by 80
Self-citationMiles, D., Freedman, M. H., Stephens, K. G., Pallavicini, M. G., Sievers, E. L., Weaver, M., Grunberger, T., Thompson, P., & Shannon, K. (1996) · Blood · doi:10.1182/blood.v88.11.4314.bloodjournal88114314 · Cited by 79
Koss, M., Scott, R. M., Irons, M., Smith, E. R., & Ullrich, N. J. (2013) · Journal of Neurosurgery Pediatrics · doi:10.3171/2012.12.peds12281 · Cited by 79
Prevalence of Sleep Disturbances in Children With Neurofibromatosis Type 1
Licis, A., Vallorani, A., Gao, F., Chen, C., Lenox, J., Yamada, K. A., Duntley, S. P., & Gutmann, D. H. (2013) · Journal of Child Neurology · doi:10.1177/0883073813500849 · Cited by 77
Self-citationImpact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases
Wolkenstein, P., Rodriguez, D., Ferkal, S., Gravier, H., Buret, V., Algans, N., Simeoni, M.-C., & Bastuji‐Garin, S. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08949.x · Cited by 75
Toonen, J. A., Anastasaki, C., Smithson, L. J., Gianino, S. M., Li, K., Kesterson, R. A., & Gutmann, D. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw039 · Cited by 75
Self-citationEpidemiology of neurofibromatosis type 1 (NF1) in northern Finland
Pöyhönen, M., KYTÖLÄ, S., & LEISTI, J. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.8.632 · Cited by 73
Heervä, E., Koffert, A., Jokinen, E., Kuorilehto, T., Peltonen, S. A., Aro, H. T., & Peltonen, J. T. K. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1685 · Cited by 73
Pheochromocytoma in von Hippel–Lindau disease and neurofibromatosis type 1
Opocher, G., Conton, P., Schiavi, F., Macino, B., & Mantero, F. (2005) · Familial Cancer · doi:10.1007/s10689-004-6128-y · Cited by 71
Attention Skills in Children With Neurofibromatosis Type 1
Isenberg, J. C., Templer, A. K., Gao, F., Titus, J. B., & Gutmann, D. H. (2012) · Journal of Child Neurology · doi:10.1177/0883073812439435 · Cited by 71
Self-citationNeurofibromatosis 1-associated neuropathies: a reappraisal
Drouet, A. (2004) · Brain · doi:10.1093/brain/awh234 · Cited by 69
Salvi, P. F., Lorenzon, L., Caterino, S., Antolino, L., Antonelli, M. S., & Balducci, G. (2013) · International Journal of Surgical Oncology · doi:10.1155/2013/398570 · Cited by 69
Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1
Terry, A. R., Jordan, J. T., Schwamm, L. H., & Plotkin, S. R. (2015) · Stroke · doi:10.1161/strokeaha.115.011406 · Cited by 69
Ndong, J. D. L. C., Makowski, A. J., Uppuganti, S., Vignaux, G., Ono, K., Perrien, D. S., Joubert, S., Baglio, S. R., Granchi, D., Stevenson, D. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3583 · Cited by 68
Mayes, D. A., Rizvi, T. A., Cancelas, J. A., Kolasinski, N. T., Ciraolo, G. M., Stemmer-Rachamimov, A. O., & Ratner, N. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4558 · Cited by 68
Sharma, R., Wu, X., Rhodes, S. D., Shi, C., He, Y., Yuan, J., Li, J., Yang, X., Li, X., Jiang, L., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt333 · Cited by 68
Vranceanu, A., Merker, V. L., Park, E. R., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1725-1 · Cited by 67
Wu, J., Dombi, E., Jousma, E., Dunn, R. S., Lindquist, D. M., Schnell, B. M., Kim, M., Kim, A., Widemann, B. C., Cripe, T. P., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23015 · Cited by 66
Toonen, J. A., Solga, A. C., Ma, Y., & Gutmann, D. H. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160447 · Cited by 65
Self-citationRenal artery stenosis and aneurysms associated with neurofibromatosis
Han, M. M., & Criado, E. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.12.021 · Cited by 64
The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults
Crawford, H., Barton, B., Wilson, M., Berman, Y. D., McKelvey‐Martin, V. J., Morrison, P. J., & North, K. N. (2015) · Journal of Genetic Counseling · doi:10.1007/s10897-015-9829-5 · Cited by 63
Achieving consensus for clinical trials: The REiNS International Collaboration
Plotkin, S. R., Blakeley, J. O., Dombi, E., Fisher, M. J., Hanemann, C. O., Walsh, K. S., Wolters, P. L., & Widemann, B. C. (2013) · Neurology · doi:10.1212/01.wnl.0000435743.49414.b6 · Cited by 63
Self-citationMasocco, M., Kodra, Y., Vichi, M., Conti, S., Kanieff, M., Pace, M., Frova, L., & Taruscio, D. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-11 · Cited by 63
Vranceanu, A., Merker, V. L., Plotkin, S. R., & Park, E. R. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1522-2 · Cited by 63
Merker, V. L., Bredella, M. A., Cai, W., Kassarjian, A., Harris, G. J., Muzikansky, A., Nguyen, R., Mautner, V. F., & Plotkin, S. R. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36466 · Cited by 62
Martin, S., Wolters, P. L., Toledo‐Tamula, M. A., Schmitt, S. N., Baldwin, A., Starosta, A., Gillespie, A., & Widemann, B. (2016) · American Journal of Medical Genetics, Part A · doi:10.1002/ajmg.a.37623 · Cited by 61
Self-citationMouse Low-Grade Gliomas Contain Cancer Stem Cells with Unique Molecular and Functional Properties
Chen, Y., McGowan, L. D., Cimino, P. J., Dahiya, S. M., Leonard, J. R., Lee, D. Y., & Gutmann, D. H. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.041 · Cited by 53
Self-citationA randomized placebo‐controlled lovastatin trial for neurobehavioral function in neurofibromatosis I
Bearden, C. E., Hellemann, G., Rosser, T. L., Montojo, C. A., Jonas, R. K., Enrique, N., Pacheco, L., Hussain, S. A., Wu, J. Y., Ho, J. S., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.288 · Cited by 53
Preimplantation diagnosis for neurofibromatosis
Verlinsky, Y., Rechitsky, S., Verlinsky, O., et al. (2002) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61809-3 · Cited by 52
Long-term Cre-mediated retrograde tagging of neurons using a novel recombinant pseudorabies virus
Oyibo, H. K., Znamenskiy, P., Oviedo, H. V., Enquist, L. W., & Zador, A. M. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00086 · Cited by 51
Sleep disturbance as part of the neurofibromatosis type 1 phenotype in adults
Leschziner, G. D., Golding, J. F., & Ferner, R. E. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35915 · Cited by 51
Self-citationOptic Nerve Dysfunction in a Mouse Model of Neurofibromatosis-1 Optic Glioma
Hegedűs, B., Hughes, F. W., Garbow, J. R., Gianino, S. M., Banerjee, D., Keun-young Kim, A., Ellisman, M. H., Brantley, M. A., & Gutmann, D. H. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a3240b · Cited by 50
Self-citationLothe, R. A., Smith‐Sørensen, B., Hektoen, M., Stenwig, A. E., Mandahl, N., Sæter, G. E., & Mertens, F. (2001) · PubMed · Cited by 49
Oostenbrink, R., Spong, K., de Goede-Bolder, A., Landgraf, J. M., Raat, H., & Moll, H. A. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.03.005 · Cited by 47
Lothe, R. A., Smith‐Sørensen, B., Hektoen, M., Stenwig, A. E., Mandahl, N., Sæter, G., & Mertens, F. (2001) · Genes Chromosomes and Cancer · Cited by 47
Toonen, J. A., Ma, Y., & Gutmann, D. H. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now267 · Cited by 46
Self-citationNeurofibromin as a regulator of melanocyte development and differentiation
Diwakar, G., Zhang, D., Jiang, S., & Hornyak, T. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.013912 · Cited by 45
Thomas, P. K., King, R. H. M., Chiang, T. R., Scaravilli, F., Sharma, A. K., & Downie, A. W. (1990) · Muscle & Nerve · doi:10.1002/mus.880130202 · Cited by 45
Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials
Wolters, P. L., Martin, S. C., Merker, V. L., Gardner, K. L., Hingtgen, C. M., Tonsgard, J. H., Schorry, E. K., & Baldwin, A. M. (2013) · Neurology · doi:10.1212/01.wnl.0000435747.02780.bf · Cited by 44
Self-citationGarwood, M. M., Bernacki, J. M., Fine, K. M., Hainsworth, K. R., Davies, W. H., & Klein-Tasman, B. (2012) · Pain Research and Treatment · doi:10.1155/2012/975364 · Cited by 43
Higher Psychological and Psychovegetative Strain in Adolescents with Atypical Pigment Naevi
Trapp, M., Egger, J. W., Kapfhammer, H., Trapp, E.-M., Rohrer, P., Hörlesberger, N., Schwantzer, G., Komericki, P., Linder, M., Lvov, A. N., et al. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-1837 · Cited by 41
Impact of ADHD in Adults With Neurofibromatosis Type 1: Associated Psychological and Social Problems
Mautner, V.-F., Granström, S., & Leark, R. A. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712450749 · Cited by 39
Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells
Li, H., Zhang, X., Fishbein, L. M., Kweh, F. A., Campbell‐Thompson, M., Perrin, G. Q., Muir, D., & Wallace, M. R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.8.12878 · Cited by 35
Nutakki, K., Hingtgen, C. M., Monahan, P. O., Varni, J. W., & Swigonski, N. L. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-21 · Cited by 32
Afridi, S. K., Leschziner, G. D., & Ferner, R. E. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37186 · Cited by 23
Self-citationc-Fms Signaling Mediates Neurofibromatosis Type-1 Osteoclast Gain-In-Functions
He, Y., Rhodes, S. D., Shi, C., Wu, X., Yuan, J., Yang, X., Jiang, L., Li, X., Takahashi, N., Xu, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046900 · Cited by 20
Improving outcomes for neurofibromatosis 1–associated brain tumors
Brossier, N. M., & Gutmann, D. H. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1009043 · Cited by 17
Self-citationParental age and Neurofibromatosis Type 1: a report from the NF1 Patient Registry Initiative
Liu, Q., Zoellner, N. L., Gutmann, D. H., & Johnson, K. J. (2014) · Familial Cancer · doi:10.1007/s10689-014-9774-8 · Cited by 15
Self-citationPrice (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Legius, E., Messiaen, L., Wolkenstein, P., Pancza, P., Avery, R. A., Berman, Y., Blakeley, J., Babovic-Vuksanovic, D., Cunha, K. S., Ferner, R., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01170-5 · Cited by 825
Self-citationWeller, M., Wen, P. Y., Chang, S. M., Dirven, L., Lim, M., Monje, M., & Reifenberger, G. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00516-y · Cited by 592
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
Ryall, S., Zapotocky, M., Fukuoka, K., Nobre, L., Guerreiro Stucklin, A., Bennett, J., Siddaway, R., Li, C., Pajovic, S., Arnoldo, A., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.011 · Cited by 474
Dendritic structural plasticity and neuropsychiatric disease
Forrest, M. P., Parnell, E., & Penzes, P. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.16 · Cited by 464
First International Consensus on the diagnosis and management of fibromuscular dysplasia
Gornik, H. L., Persu, A., Adlam, D., Aparicio, L. S., Azizi, M., Boulanger, M., Bruno, R. M., de Leeuw, P., Fendrikova-Mahlay, N., Froehlich, J., et al. (2019) · Vascular Medicine · doi:10.1177/1358863x18821816 · Cited by 432
Metadata
- Authors
- Gutmann, D. H., Ferner, R. E., Listernick, R. H., Korf, B. R., Wolters, P. L., & Johnson, K. J.
- Venue
- Nature Reviews Disease Primers
- Published
- 2017-02-23
- Volume
- 3
- Issue
- 1
- Pages
- 17004-17004
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W2591172233
- Cited by
- 862
- References
- 183
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.